Cases & Deals

Sanofi sells eight brands to Hypera Pharma

Clients Sanofi

Jones Day is advising Sanofi in the sale to Hypera of 12 over-the-counter and prescription brands in Brazil, Colombia and Mexico, including mouthwash Cepacol and antipyretic AAS. The transaction is expected to close at the end of 2021, subject to approval of relevant regulatory authorities and other customary closing conditions.